mRNA COVID-19 vaccines effective in cirrhosis patients, study finds

U.S. veterans experiencing cirrhosis, or damage to the liver, and who also received an mRNA COVID-19 vaccine saw high levels of protection against virus-related hospitalization and death, a study found.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.